Feb 20 (Reuters) - FibroGen Inc FGEN.O:
FIBROGEN ANNOUNCES THE SALE OF FIBROGEN CHINA TO ASTRAZENECA FOR APPROXIMATELY $160 MILLION
FIBROGEN INC - ANNOUNCES SALE OF CHINA SUBSIDIARY TO ASTRAZENECA FOR $160 MILLION
FIBROGEN INC - CASH RUNWAY EXTENDED INTO 2027
Source text: ID:nGNXtnJ8x
Further company coverage: FGEN.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.